IRB Approval letter

APPROVAL
February 22, 2018
Jane Allen
919-597-5115, x25115
[email protected]
Dear Jane Allen:
On 2/22/2018, the IRB reviewed the following submission:
Type of Review: Initial Study
Title: Investigation of Consumer Perceptions of Expressed
Modified Risk Claims (Expressed Claims) – Main
Study
Investigator: Jane Allen
IRB ID: STUDY00020056
Funding Source: FDA Ctr Tobacco Products
Customer/Client Name: DHHS FDA OAGS
Project/Proposal Number: 0212926.028
IND, IDE, or HDE: None
The IRB approved the study from 2/22/2018to 2/21/2019 inclusive. Before 2/21/2019 or within
30 days of study close, whichever is earlier, you are to submit a completed continuing review
and required attachments to request continuing approval or closure. You can submit a continuing
review by navigating to the active study and clicking Create Modification / CR.
If continuing review approval is not granted before the expiration date of 2/21/2019, approval of
this study expires on that date.
In conducting this study, you are required to follow the requirements listed in the Investigator
Manual (HRP-103), which can be found by navigating to the IRB Library within the IRB system.
Sincerely,
The RTI Office of Research Protection